Pharmacy

Twenty-five years ago, top executives from the nation's seven largest tobacco companies were brought before Congress to answer long-standing questions about the dangers of cigarettes. The hearing ultimately brought sweeping changes to the tobacco industry and drove smoking rates to…

As the debate about rising drug costs heats up between pharmacy benefit managers and drugmakers, Sanofi released a report revealing that it shelled out $12 million in rebates to PBMs and insurers last year. The amount is more than half…

As disruptors continue to push into the healthcare arena and pressure builds to cut drug prices, pharmaceutical companies are taking steps to remain competitive and enhance their drug pipelines.

The New York Times editorial board laid out five questions the Senate Finance Committee should ask the seven pharmaceutical companies testifying at a hearing Feb. 26.

Danaher Corp., a Fortune 500 science and technology conglomerate, will buy General Electric's biotechnology business for $21.4 billion in cash, according to CNBC.

Drug giant Roche will buy gene therapy developer Spark Therapeutics for about $4.8 billion in cash, according to Bloomberg.

The Senate Finance Committee has launched an investigation into steeply rising U.S. insulin prices, according to Reuters.

Seven Big Pharma executives are set to testify before the Senate Finance Committee in a hearing Feb. 26. What you need to know:

Here are five pharmaceutical companies that filed for bankruptcy protection since Feb. 1:

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leadership talent in the last week.